A Randomized SAD and MAD Study Evaluating the Safety and Tolerability of RPh201 in Healthy Subjects and in Adults With Alzheimer's Disease

Clinical trial NCT01513967 · COMPLETED

Trial details

NCT number: NCT01513967
Sponsor: Regenera Pharma Ltd
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Healthy Volunteers Moderate to Severe Alzheimer Patients

Start date: 2012-01-01
Primary completion: 2015-06-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.